• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过用灭活全病毒疫苗加强免疫诱导的高亲和力血清抗体有效保护小鼠免受甲型H1N1pdm09流感病毒攻击感染。

Efficient protection of mice from influenza A/H1N1pdm09 virus challenge infection via high avidity serum antibodies induced by booster immunizations with inactivated whole virus vaccine.

作者信息

Sato Kayoko, Takahashi Yoshimasa, Adachi Yu, Asanuma Hideki, Ato Manabu, Tashiro Masato, Itamura Shigeyuki

机构信息

Influenza Virus Research Center, National Institute of Infectious Diseases, Musashimurayama-shi, Tokyo, Japan.

Department of Immunology, National Institute of Infectious Diseases, Shinjuku-ku, Tokyo, Japan.

出版信息

Heliyon. 2019 Jan 3;5(1):e01113. doi: 10.1016/j.heliyon.2018.e01113. eCollection 2019 Jan.

DOI:10.1016/j.heliyon.2018.e01113
PMID:30623129
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6319303/
Abstract

The immunogenicities of inactivated whole and split virus vaccines derived from influenza A/H1N1pdm09 virus were compared in a mouse model. We demonstrated the unique properties of whole virus vaccine boosters on the serum memory antibody response in mice. Consistent with previous studies, booster immunization with either whole or split virus vaccines of A/H1N1pdm09 virus produced comparable titers of serum antibodies with hemagglutination inhibition and virus-neutralizing activities. However, superior protection against the challenge infection was unexpectedly observed in mice primed and boosted with whole virus vaccines compared with those treated with split virus vaccines, despite similar levels of antibody titers in each group. Immune serum antibodies were shown to be primarily responsible for this protection via passive transfer experiments of immune serum antibodies to naive recipient mice. Moreover, this protection correlated with elevated affinity maturation of the antibodies. Thus, booster immunization with whole virus vaccines elicited a robust serum antibody response with high avidity to the virus, which was not measurable via conventional serological assays.

摘要

在小鼠模型中比较了源自甲型H1N1pdm09流感病毒的灭活全病毒疫苗和裂解病毒疫苗的免疫原性。我们证明了全病毒疫苗加强免疫对小鼠血清记忆抗体反应的独特特性。与先前的研究一致,用甲型H1N1pdm09病毒的全病毒疫苗或裂解病毒疫苗进行加强免疫产生了具有血凝抑制和病毒中和活性的相当滴度的血清抗体。然而,尽管每组抗体滴度水平相似,但与用裂解病毒疫苗处理的小鼠相比,用全病毒疫苗进行初免和加强免疫的小鼠对攻击感染的保护作用出人意料地更强。通过将免疫血清抗体被动转移到未免疫的受体小鼠的实验表明,免疫血清抗体是这种保护作用的主要原因。此外,这种保护作用与抗体亲和力成熟度的提高相关。因此,用全病毒疫苗进行加强免疫引发了对病毒具有高亲和力的强大血清抗体反应,这是通过传统血清学检测无法测量的。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f19/6319303/dd1ca4774230/gr8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f19/6319303/b95d1d91a580/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f19/6319303/5f0209805eed/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f19/6319303/6d2ae63a028c/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f19/6319303/0a9dd8994a44/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f19/6319303/643115d8138b/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f19/6319303/c79d4fc743c7/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f19/6319303/2eedffe658fd/gr7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f19/6319303/dd1ca4774230/gr8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f19/6319303/b95d1d91a580/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f19/6319303/5f0209805eed/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f19/6319303/6d2ae63a028c/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f19/6319303/0a9dd8994a44/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f19/6319303/643115d8138b/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f19/6319303/c79d4fc743c7/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f19/6319303/2eedffe658fd/gr7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f19/6319303/dd1ca4774230/gr8.jpg

相似文献

1
Efficient protection of mice from influenza A/H1N1pdm09 virus challenge infection via high avidity serum antibodies induced by booster immunizations with inactivated whole virus vaccine.通过用灭活全病毒疫苗加强免疫诱导的高亲和力血清抗体有效保护小鼠免受甲型H1N1pdm09流感病毒攻击感染。
Heliyon. 2019 Jan 3;5(1):e01113. doi: 10.1016/j.heliyon.2018.e01113. eCollection 2019 Jan.
2
Inactivated H7 Influenza Virus Vaccines Protect Mice despite Inducing Only Low Levels of Neutralizing Antibodies.灭活H7流感病毒疫苗尽管仅诱导产生低水平的中和抗体,但仍可保护小鼠。
J Virol. 2017 Sep 27;91(20). doi: 10.1128/JVI.01202-17. Print 2017 Oct 15.
3
Influenza Virus Hemagglutinin Stalk-Specific Antibodies in Human Serum are a Surrogate Marker for Protection in a Serum Transfer Mouse Challenge Model.人血清中流感病毒血凝素茎特异性抗体是血清转移小鼠攻毒模型中保护作用的替代标志物。
mBio. 2017 Sep 19;8(5):e01463-17. doi: 10.1128/mBio.01463-17.
4
Bacterium-like particles supplemented with inactivated influenza antigen induce cross-protective influenza-specific antibody responses through intranasal administration.细菌样颗粒佐以灭活流感抗原经鼻内给药诱导交叉保护性流感特异性抗体应答。
Vaccine. 2012 Jul 6;30(32):4884-91. doi: 10.1016/j.vaccine.2012.04.032. Epub 2012 Apr 23.
5
Head-to-head comparison of four nonadjuvanted inactivated cell culture-derived influenza vaccines: effect of composition, spatial organization and immunization route on the immunogenicity in a murine challenge model.四种非佐剂细胞培养衍生流感疫苗的直接比较:在小鼠攻毒模型中,疫苗成分、空间结构和免疫途径对免疫原性的影响
Vaccine. 2008 Dec 2;26(51):6555-63. doi: 10.1016/j.vaccine.2008.09.057.
6
Hemagglutinin-Specific Non-neutralizing Antibody Is Essential for Protection Provided by Inactivated and Viral-Vectored H7N9 Avian Influenza Vaccines in Chickens.血凝素特异性非中和抗体对于灭活和病毒载体H7N9禽流感疫苗在鸡体内提供的保护至关重要。
Front Vet Sci. 2020 Jan 9;6:482. doi: 10.3389/fvets.2019.00482. eCollection 2019.
7
A cell culture-derived whole-virus H5N1 vaccine induces long-lasting cross-clade protective immunity in mice which is augmented by a homologous or heterologous booster vaccination.细胞培养衍生的全病毒 H5N1 疫苗可诱导小鼠产生持久的跨谱系保护免疫,同源或异源加强免疫可增强这种免疫。
Vaccine. 2012 Aug 10;30(37):5533-40. doi: 10.1016/j.vaccine.2012.06.043. Epub 2012 Jun 29.
8
Cross-Protective Immune Responses Induced by Sequential Influenza Virus Infection and by Sequential Vaccination With Inactivated Influenza Vaccines.先后感染流感病毒和先后接种流感灭活疫苗诱导的交叉保护免疫应答。
Front Immunol. 2018 Oct 9;9:2312. doi: 10.3389/fimmu.2018.02312. eCollection 2018.
9
Vaccine-associated enhanced respiratory disease does not interfere with the adaptive immune response following challenge with pandemic A/H1N1 2009.疫苗相关增强性呼吸道疾病并不会干扰大流行性 A/H1N1 2009 感染后的适应性免疫应答。
Viral Immunol. 2013 Oct;26(5):314-21. doi: 10.1089/vim.2013.0018. Epub 2013 Sep 13.
10
Vaccine Efficacy of Inactivated, Chimeric Hemagglutinin H9/H5N2 Avian Influenza Virus and Its Suitability for the Marker Vaccine Strategy.灭活嵌合血凝素H9/H5N2禽流感病毒的疫苗效力及其对标记疫苗策略的适用性
J Virol. 2017 Feb 28;91(6). doi: 10.1128/JVI.01693-16. Print 2017 Mar 15.

引用本文的文献

1
Two doses of Qβ virus like particle vaccines elicit protective antibodies against heroin and fentanyl.两剂Qβ病毒样颗粒疫苗可引发针对海洛因和芬太尼的保护性抗体。
NPJ Vaccines. 2025 Mar 28;10(1):57. doi: 10.1038/s41541-025-01105-0.
2
Synthesis and Optimization of Next-Generation Low-Molecular-Weight Pentablock Copolymer Nanoadjuvants.下一代低分子量五嵌段共聚物纳米佐剂的合成与优化
Vaccines (Basel). 2023 Oct 9;11(10):1572. doi: 10.3390/vaccines11101572.
3
SARS-CoV-2 IgG Spike antibody levels and avidity in natural infection or following vaccination with mRNA-1273 or BNT162b2 vaccines.

本文引用的文献

1
Evaluation of Antihemagglutinin and Antineuraminidase Antibodies as Correlates of Protection in an Influenza A/H1N1 Virus Healthy Human Challenge Model.在甲型H1N1流感病毒健康人体激发模型中评估抗血凝素和抗神经氨酸酶抗体作为保护相关性指标的研究
mBio. 2016 Apr 19;7(2):e00417-16. doi: 10.1128/mBio.00417-16.
2
Whole-Virion Influenza Vaccine Recalls an Early Burst of High-Affinity Memory B Cell Response through TLR Signaling.全病毒流感疫苗通过TLR信号通路唤起早期高亲和力记忆B细胞反应的爆发。
J Immunol. 2016 May 15;196(10):4172-84. doi: 10.4049/jimmunol.1600046. Epub 2016 Apr 6.
3
Host Adaptation and the Alteration of Viral Properties of the First Influenza A/H1N1pdm09 Virus Isolated in Japan.
SARS-CoV-2 IgG 刺突抗体水平和亲和力在自然感染或接种 mRNA-1273 或 BNT162b2 疫苗后。
Hum Vaccin Immunother. 2023 Aug 1;19(2):2215677. doi: 10.1080/21645515.2023.2215677. Epub 2023 Jun 1.
4
The Potential of Neuraminidase as an Antigen for Nasal Vaccines To Increase Cross-Protection against Influenza Viruses.神经氨酸酶作为鼻腔疫苗抗原增加对流感病毒交叉保护的潜力。
J Virol. 2021 Sep 27;95(20):e0118021. doi: 10.1128/JVI.01180-21. Epub 2021 Aug 11.
日本分离出的首例甲型H1N1pdm09流感病毒的宿主适应性及病毒特性改变
PLoS One. 2015 Jun 16;10(6):e0130208. doi: 10.1371/journal.pone.0130208. eCollection 2015.
4
Novel drugs targeting Toll-like receptors for antiviral therapy.用于抗病毒治疗的靶向Toll样受体的新型药物。
Future Virol. 2014 Sep;9(9):811-829. doi: 10.2217/fvl.14.70.
5
WHO recommendations for the viruses used in the 2013-2014 Northern Hemisphere influenza vaccine: Epidemiology, antigenic and genetic characteristics of influenza A(H1N1)pdm09, A(H3N2) and B influenza viruses collected from October 2012 to January 2013.世界卫生组织关于2013 - 2014年北半球流感疫苗所用病毒的建议:2012年10月至2013年1月收集的甲型H1N1pdm09流感病毒、甲型H3N2流感病毒和乙型流感病毒的流行病学、抗原性及基因特征
Vaccine. 2014 Aug 20;32(37):4713-25. doi: 10.1016/j.vaccine.2014.02.014. Epub 2014 Feb 28.
6
Influenza A whole virion vaccine induces a rapid reduction of peripheral blood leukocytes via interferon-α-dependent apoptosis.甲型流感全病毒疫苗通过干扰素-α依赖性细胞凋亡快速减少外周血白细胞。
Vaccine. 2013 Apr 19;31(17):2184-90. doi: 10.1016/j.vaccine.2013.02.016. Epub 2013 Feb 19.
7
Cross-reactive influenza-specific antibody-dependent cellular cytotoxicity antibodies in the absence of neutralizing antibodies.无中和抗体时的交叉反应性流感特异性抗体依赖的细胞细胞毒性抗体。
J Immunol. 2013 Feb 15;190(4):1837-48. doi: 10.4049/jimmunol.1201574. Epub 2013 Jan 14.
8
Correlates of protection to influenza virus, where do we go from here?流感病毒保护相关因素,我们的路在何方?
Hum Vaccin Immunother. 2013 Feb;9(2):405-8. doi: 10.4161/hv.22908. Epub 2013 Jan 4.
9
Inactivated and adjuvanted whole-virion clade 2.3.4 H5N1 pre-pandemic influenza vaccine possesses broad protective efficacy against infection by heterologous clades of highly pathogenic H5N1 avian influenza virus in mice.灭活及佐剂全病毒 2.3.4 分支 H5N1 大流行前流感疫苗在小鼠中对异源高致病性 H5N1 禽流感病毒具有广泛的保护效力。
Vaccine. 2011 Oct 26;29(46):8330-7. doi: 10.1016/j.vaccine.2011.08.091. Epub 2011 Sep 10.
10
Severe pandemic 2009 H1N1 influenza disease due to pathogenic immune complexes.严重大流行 2009 年 H1N1 流感疾病是由致病免疫复合物引起的。
Nat Med. 2011 Feb;17(2):195-9. doi: 10.1038/nm.2262. Epub 2010 Dec 5.